Copyright
©The Author(s) 2021.
World J Transplant. Oct 18, 2021; 11(10): 410-420
Published online Oct 18, 2021. doi: 10.5500/wjt.v11.i10.410
Published online Oct 18, 2021. doi: 10.5500/wjt.v11.i10.410
Goals | Monitoring |
MAP ≥ 65 mmHg | Invasive arterial pressure |
CVP ≥ 10 | Central venous catheter |
Hemoglobin ≥ 10 g/dL | Blood gas analysis |
Diuresis ≥ 1 mL/kg/h | |
Na 135-155 meq/L |
Dosage | Comments | |
Vasoactive | ||
Norepinephrine (mcg/kg/min) | ≤ 0.2 mcg/kg/min, if higher dosage needed add vasopressin | In potential heart donors, the lowest dosage is preferable |
Vasopressin (U/h) | Up to 2.5 U/h | |
Hormonal replacement therapy | ||
Idrocorticosteroid | 100 mg bolus, 200 mg/24 h infusion | |
T3 | 4 mcg intravenous bolus, followed by infusion of 3 mcg per hour | T3 could be preferred since it is immediately available to tissues |
Desmopressin (DDVAP) | 4 mcg intravenous bolus eventually repeat every 6 to 8 h as needed |
- Citation: Lazzeri C, Bonizzoli M, Guetti C, Fulceri GE, Peris A. Hemodynamic management in brain dead donors. World J Transplant 2021; 11(10): 410-420
- URL: https://www.wjgnet.com/2220-3230/full/v11/i10/410.htm
- DOI: https://dx.doi.org/10.5500/wjt.v11.i10.410